Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.

Centessa Pharmaceuticals, founded from the merger of 10 biotech companies, is based on an asset-centric model, primarily ...

Mazindol ER is under clinical development by NLS Pharmaceutics and currently in Phase II for Narcolepsy. According to GlobalData, Phase II drugs for Narcolepsy have a 59% phase transition success rate ...

Pitolisant hydrochloride is under clinical development by Bioprojet SCR and currently in Phase II for Autism Spectrum Disorder (ASD).

The contact-free sleep monitoring systems market is projected to grow at an 8.1% CAGR, reaching $214.7 million by 2033 from ...

INR:8442. boylesports 30 free bet The only non-regulated narcolepsy drug! Wakix is ​​approved by the US FDA for a new indication 5500 down to 123, fou ...

Spiromacrocyclic compounds acting as orexin OX2 receptor agonists have been described in an H. Lundbeck A/S patent and reported to be useful for the treatment of type 1 and type 2 narcolepsy.

INR:3960. dp boss net FDA approves innovative narcolepsy treatment Grifols acquires proteomics startup for $146 million CDE issues a trial notice on the working proce ...

Lack of sleep is an obvious energy drainer. Discover why you’re always so tired: Finding true rejuvenation beyond sleep: ...

Born in 1991, Lauren has faced significant health challenges, including a narcolepsy diagnosis in 2019. Lauren has shared her story on platforms such as NPR, Project Sleep’s Narcolepsy Nerd Alert ...

INR:1852. cricket world cup tickets 2023 After struggling for a month, this private hospital in Wuhan finally received "public treatment" Jazz's ne ...

Canfield solitaire free game lab 6 new drugs approved for clinical development for the treatment of narcolepsy, anal canal ...